Clinical Trial Update: HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose [Phase 2, Phase 3]

View source ↗

Summary

Update on the HEALEY ALS Platform Trial Regimen E SLS-005 with trehalose is complete, and results have been posted. The study targets amyotrophic lateral sclero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Trehalose (trehalose)

Snippet

Sponsor: Merit E. Cudkowicz, MD | Conditions: Amyotrophic Lateral Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-08-28